Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07606820
NA

Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea

Sponsor: The First Affiliated Hospital with Nanjing Medical University

View on ClinicalTrials.gov

Summary

A Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-10-29

Completion Date

2026-04-30

Last Updated

2026-07-21

Healthy Volunteers

No

Conditions

Interventions

DRUG

Crisugabalin(HSK16149)20mg BID

different dose

DRUG

Crisugabalin(HSK16149) 20mg qd

different dose

Locations (1)

Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Nanjing, Jiangsu, China